<DOC>
	<DOCNO>NCT01493947</DOCNO>
	<brief_summary>Study objective : - To compare efficacy safety Ivermectin 1 % cream versus metronidazole 0.75 % cream subject papulopustular rosacea 16-week topical treatment . - And compare , subject initially successfully treated 16 week treatment , Ivermectin 1 % cream versus metronidazole 0.75 % cream 36-week extension period assess , time first relapse , relapse rate , number day free treatment</brief_summary>
	<brief_title>CD5024 1 % Ivermectin 1 % Cream Versus Metronidazole 0.75 % Cream Papulopustular Rosacea ( PPR ) Study</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Ivermectin</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Subjects papulopustular rosacea score 3 ( moderate ) 4 ( severe ) accord Investigator Global Assessment ( IGA ) , Subjects least 15 70 inflammatory lesion ( papule pustule ) face . Subjects particular form rosacea ( rosacea conglobate , rosacea fulminant , isolated rhinophyma , isolated pustulosis chin ) facial dermatosis may confound papulopustular rosacea , peri oral dermatitis , facial keratosis pilar , seborrheic dermatitis acne , Subjects rosacea two nodule face .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>